| Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies S Gebremeskel, B Johnston Oncotarget 6 (39), 41600, 2015 | 135 | 2015 |
| The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer S Gebremeskel, T LeVatte, RS Liwski, B Johnston, M Bezuhly International journal of cancer 136 (1), 234-240, 2015 | 133 | 2015 |
| Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune … R Aslam, Y Hu, S Gebremeskel, GB Segel, ER Speck, L Guo, M Kim, H Ni, ... Blood, The Journal of the American Society of Hematology 120 (10), 2127-2132, 2012 | 113 | 2012 |
| Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody S Gebremeskel, J Schanin, KM Coyle, M Butuci, T Luu, EC Brock, A Xu, ... Frontiers in immunology 12, 650331, 2021 | 108 | 2021 |
| Alternatively activated M2 macrophages improve autologous fat graft survival in a mouse model through induction of angiogenesis KD Phipps, S Gebremeskel, J Gillis, P Hong, B Johnston, M Bezuhly Plastic and reconstructive surgery 135 (1), 140-149, 2015 | 85 | 2015 |
| Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer AJ Gareau, C Brien, S Gebremeskel, RS Liwski, B Johnston, M Bezuhly Clinical & experimental metastasis 35, 25-35, 2018 | 74 | 2018 |
| Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice S Gebremeskel, DR Clattenburg, D Slauenwhite, L Lobert, B Johnston Oncoimmunology 4 (3), e995562, 2015 | 70 | 2015 |
| A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation J Schanin, S Gebremeskel, W Korver, R Falahati, M Butuci, TJ Haw, ... Mucosal immunology 14 (2), 366-376, 2021 | 63 | 2021 |
| Reovirus FAST protein enhances vesicular stomatitis virus oncolytic virotherapy in primary and metastatic tumor models F Le Boeuf, S Gebremeskel, N McMullen, H He, AL Greenshields, ... Molecular Therapy-Oncolytics 6, 80-89, 2017 | 57 | 2017 |
| Natural killer T-cell immunotherapy in combination with chemotherapy-induced immunogenic cell death targets metastatic breast cancer S Gebremeskel, L Lobert, K Tanner, B Walker, T Oliphant, LE Clarke, ... Cancer immunology research 5 (12), 1086-1097, 2017 | 47 | 2017 |
| Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and … S Gebremeskel, A Nelson, B Walker, T Oliphant, L Lobert, D Mahoney, ... Journal for immunotherapy of cancer 9 (3), 2021 | 42 | 2021 |
| CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control L Veinotte, S Gebremeskel, B Johnston Oncoimmunology 5 (6), e1160979, 2016 | 38 | 2016 |
| Effect of N-acetylcysteine on adipose-derived stem cell and autologous fat graft survival in a mouse model J Gillis, S Gebremeskel, KD Phipps, LA MacNeil, CJ Sinal, B Johnston, ... Plastic and reconstructive surgery 136 (2), 179e-188e, 2015 | 36 | 2015 |
| Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy AM Szczesniak, RF Porter, JT Toguri, J Borowska-Fielding, ... Neuropharmacology 113, 627-638, 2017 | 35 | 2017 |
| Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2 W Qiu, R Lam, O Voytyuk, V Romanov, R Gordon, S Gebremeskel, ... Acta Crystallographica Section D: Biological Crystallography 70 (10), 2740-2753, 2014 | 32 | 2014 |
| Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas B Dawod, J Liu, S Gebremeskel, C Yan, A Sappong, B Johnston, ... Scientific reports 10 (1), 13343, 2020 | 30 | 2020 |
| Selective cannabinoid 2 receptor agonists as potential therapeutic drugs for the treatment of endotoxin-induced uveitis RF Porter, AM Szczesniak, JT Toguri, S Gebremeskel, B Johnston, ... Molecules 24 (18), 3338, 2019 | 30 | 2019 |
| Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking DP Corkery, LE Clarke, S Gebremeskel, J Salsman, J Pinder, C Le Page, ... Oncogene 37 (2), 174-184, 2018 | 27 | 2018 |
| Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen‐induced arthritis by the chemokine receptor CXCR6 D Slauenwhite, S Gebremeskel, CD Doucette, DW Hoskin, B Johnston Arthritis & rheumatology 66 (11), 3001-3012, 2014 | 26 | 2014 |
| Promotion of primary murine breast cancer growth and metastasis by adipose-derived stem cells is reduced in the presence of autologous fat graft S Gebremeskel, J Gencarelli, AJ Gareau, T Levatte, A Dugandzic, ... Plastic and reconstructive surgery 143 (1), 137-147, 2019 | 24 | 2019 |
Brent JohnstonDepartment of Microbiology & Immunology, Dalhousie University在 dal.ca 的电子邮件经过验证
